Publication | Closed Access
A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer.
49
Citations
19
References
2007
Year
A change in hMLH1 MET is a major molecular cause of acquired resistance to Pt-chemo in EOC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1